Drug Prices – Page 16 – Policy & Medicine

Senate Passes FY 2019 Funding Bill With Bipartisan Vote – Includes Funds for DTC Price Disclosure

Medicare Part D Premiums Continue to Decline

Mayo Clinic Releases Paper on Cancer Drug Pricing Economic Trade-offs

Subcommittee on Health to Hold Hearing on Reforming the 340B Drug Pricing Program

Azar Continues to Promote Administration Drug Pricing Policy, Plus RFI Published on Stark Law

Is HHS Committed to Lowering Drug Prices?

FDA Publishes List of Drug Companies Allegedly Blocking Access to Drug Samples

Senate Holds Hearing on Pricing of Insulin

Vermont’s Next Act: Wholesale Prescription Drug Importation Program

President Trump Gives Remarks on Lowering Drug Prices